John R. Eckardt
Cleveland Clinic(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Cancer Treatment and Pharmacology, Neutropenia and Cancer Infections
Most-Cited Works
- → Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer(2007)380 cited
- → Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.(1996)352 cited
- → Phase I and pharmacokinetic trial of weekly CPT-11.(1993)303 cited
- → Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.(1995)152 cited
- → Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer(2006)147 cited
- → Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.(1993)135 cited
- → Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies(1999)133 cited
- → Heat shock proteins and drug resistance(1994)103 cited
- → Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.(1995)95 cited
- → Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer(2009)91 cited